chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swollen lymphnodes in armpit of right arm; The patient received Johnson and Johnson vaccine on 08Mar2021 and received booster dose of BNT162b2; The patient received Johnson and Johnson vaccine on 08Mar2021 and received booster dose of BNT162b2; The patient received booster dose of BNT162b2; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received the second (booster) dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 30155BA) via an unspecified route of administration in the right arm on an unknown date in 2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. The patient had known allergies to shellfish. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient received other vaccines within four weeks of vaccination which included tetanus vaccine toxoid/ diphtheria vaccine toxoid/ pertussis vaccine acellular 5-component (ADACEL) and influenza vaccine (MANUFACTURER UNKNOWN); both via an unspecified route of administration in the right arm on 07Oct2021 for immunization. The patient previously received COVID-19 vaccine NRVV AD26 (JOHNSON AND JOHNSON VACCINE; Lot Number: 1805020) via an unspecified route of administration in the right arm on 08Mar2021 at 10:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. On 01Nov2021, the patient experienced swollen lymphnodes in armpit of right arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymphnodes in armpit of right arm was not resolved at the time of the report.
Patient reported significant nausea/vomiting starting day after vaccine dose to post vaccine hotline. Patient directed to see additional care via PCP/urgent care. Unknown if patient sought additional care. Per notes patient has prior history of nausea/vomiting episodes.
On 11-24-10 patient's son stated mom's left upper arm (deltoid muscle) still hurt from shot given on 10-19-10. He stated she could not lift arm shortly after the injection but thought it would wear off. Today is 11-24-10. Pt saw regular MD. He gave her Prednisone which helped a bit ( 2 x 16d) 11-12-10.
After a week of no issues on my left arm, I developed a raised, red, hot-to-the-touch, itchy rash at the injection site that grew from about a 1" x 2" oval, to a 4" x 5" oval over the course of three days. After that, the rash started to decrease and over another two days had disappeared completely.
itchy, arm, face, tongue, back of throat. No difficulty breathing.  No swelling of tongue or throat.  Vitals stable.  Given 50 Benadryl oral.  symptoms gradually subsided.
A couple days after the vaccination I had headache, myalgia, fever,  chills and lost my sense of smell.  And on 12/26 I tested positive for COVID-19 after the vaccination.
Strange pains in unusual places, not just injection site. Headache started on left side of neck heading to bad headache. Headache ceased upon sleeping, but was still present when awakened by nature around 2am. Woke up around 6am and still have headache. Just noticed my feet swelling, left is moreso than right. Slight dizziness (even while sitting). This morning, throat feels tight, as if being choked.
Left shoulder pain started 2 days after flu shot on 10/28/21. Pain radiates from shoulder down to wrist and causes my daughter to guard her arm. It is sore to the touch. We followed up with an urgent care video visit and Physical therapy thus far. Treatment is ongoing and reached out to her primary care provider to see if an MRI is necessary, as the pain has been ongoing for almost 3 months.
This spontaneous report as received from a registered nurse (R.N.) refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 30-SEP-2015, the patient was inadvertently vaccinated with a dose of improperly stored GARDASIL 9 injection (lot # L013429, expiration date 21-JUL-2017, dose and route of administration were not provided). No adverse effects were reported. Additional information is not expected as the reporter did not wish to be contacted.
The burning and stinging is also under each arm.; stinging progressed on 3APR2022 to burning in both of her arms; patient noticed a stinging in her left arm/ stinging progressed to burning in both of her arms; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (stinging progressed on 3APR2022 to burning in both of her arms), PAIN IN EXTREMITY (patient noticed a stinging in her left arm/ stinging progressed to burning in both of her arms) and AXILLARY PAIN (The burning and stinging is also under each arm.) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L21A, 011F21A and 017E21A) for COVID-19 vaccination.     It was reported that the patient had no history of COVID-19 infection. Patient did not have history of Myocarditis/pericarditis.  Concomitant products included LEVOTHYROXINE for an unknown indication.   On 13-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 31-Mar-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (patient noticed a stinging in her left arm/ stinging progressed to burning in both of her arms). On 03-Apr-2022, the patient experienced BURNING SENSATION (stinging progressed on 3APR2022 to burning in both of her arms). On an unknown date, the patient experienced AXILLARY PAIN (The burning and stinging is also under each arm.). At the time of the report, BURNING SENSATION (stinging progressed on 3APR2022 to burning in both of her arms), PAIN IN EXTREMITY (patient noticed a stinging in her left arm/ stinging progressed to burning in both of her arms) and AXILLARY PAIN (The burning and stinging is also under each arm.) outcome was unknown.            Patient received the first Moderna COVID-19 booster dose on 31-Mar-2022.  No information on treatment medications was reported.    This case was linked to MOD-2022-547011, MOD-2022-547014 (Patient Link).
Patient started to feel unwell with fatigue, a fever, numbness on her face, and a severe headache following the vaccine. Later that week, patient's headache was still severe, and she started to complain about feeling dizzy and light-headed. Patient also began to have weakness and tingling and weakness in arms and legs, with it more severe in her left leg. Patient has since been diagnosed with Dysautonomia, POTS - Orthostatic hypotension, Gastroparesis and GI dysmotility, and joint hypermobility. She will get light-headed if she stands too quickly and passes out. Her heart rate jumps up to the 160s and 170a and at times jumps up to the 200s, while at the same time her blood pressure drops, which is what causes her to pass out. She has needed to have a GJ tube surgically placed in her stomach to allow food to bypass her stomach so that it moves more quickly. She has lost almost fifty pounds since she received the vaccine due to her gastroparesis. She also has a walking cane that she uses to help her with walking to help keep her steady. Patient had to switch to virtual classes due to missing so much school for doctor's visits and hospital stays.
Headache, Myalgia, pain & swelling injection site, chills, fatigue, metallic taste, general stiffness
This report is the same as for cases 200501561, 200600062, 200600063, and 200600064. Follow information received 2/13/06 from a health care provider. The reporter writes left thigh cellulitis next to the event of injection site reaction on the VAERS form. Additional information is not provided. Follow up information received on 6/8/06 from a health care professional. It was reported that the pt had no illness at the time of vaccination. She had no significant past medical history and no adverse events following prior vaccination. The pt was treated for the events with unspecified antibiotics. No further information is anticipated.
It was reported post vaccine pt developed an injection site reaction characterized by redness, swelling, and heat at an unspecified site.
fever develop on day 1 1(/18/2021) which was up to 102. On  Day 2 (1/19/2021) she had fever of 100.8 she also  developed headache, fatigue, weakness  nausea vomiting nausea and diarrhea. Day 3 -(1/20/2021) was the same symptoms as day 2. She started to feel somewhat better on day 4 and 5 1/21/2021 and 1/22/2021 but still wasn?t eating and felt fatigued.  Day 6 1/23/2021 to present she is still somewhat weak.
non-itchy popped up with Pustules; systemic rash; injection Site Rash; blotches "like old-lady marks"; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (blotches "like old-lady marks"), RASH PUSTULAR (non-itchy popped up with Pustules), RASH (systemic rash) and VACCINATION SITE RASH (injection Site Rash) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Flu (Flu shot: Arm swollen and in some area of shot. Have Flu shot every year-No problem now.) on 11-Jan-2005.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (blotches "like old-lady marks"), RASH PUSTULAR (non-itchy popped up with Pustules), RASH (systemic rash) and VACCINATION SITE RASH (injection Site Rash). At the time of the report, RASH MACULAR (blotches "like old-lady marks"), RASH PUSTULAR (non-itchy popped up with Pustules), RASH (systemic rash) and VACCINATION SITE RASH (injection Site Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment and concomitant medications were provided.   This case was linked to MOD-2021-255288.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow up information received,  No new information received. On 28-Jul-2021: Follow up received and includes the historical condition.
This spontaneous report was received from a field representative concerning to a female patient of unknown age who is also a physician. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were unknown by the reporter. In approximately February 2004 (reported as "10-15 years ago"), the patient was vaccinated with PNEUMOVAX 23 injection, to prevent pneumonia (dose, dose number, route of administration, anatomical location, lot/batch # and expiration date were unknown by the reporter). On an unknown date, the patient experienced an upper respiratory infection. It was unknown by the reporter if the patient sought medical attention or if any laboratory diagnostics, studies, intervention to prevent serious criteria, or treatment was given for the adverse event. No additional information was provided. The outcome of upper respiratory tract infection was reported as recovered. The reporter did not provide a causal relationship between the event and vaccination with PNEUMOVAX 23.
This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with ZOSTAVAX (route, dose and lot # unknown). No other co-suspects were reported. No concomitant medications were reported. On an unknown date the patient developed shingles within one month after they received ZOSTAVAX. At the report time the outcome of event was unknown. It was unknown if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
Extreme vertigo onset about 7 days after second shot; The vertigo lasted several days and caused patient to miss work and hobbies; Swelling/inflammation of previous melanoma site and surgical scar on inner left arm (vaccination site was also left arm) - no other scars were inflamed during this time; Swelling/inflammation of previous melanoma site and surgical scar on inner left arm (vaccination site was also left arm) - no other scars were inflamed during this time; Very uncomfortable and alarming side effect; Swollen lymph nodes on left side of neck; This is a spontaneous report from a contactable consumer or other non-health care professional. A 41-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: solution for injection, Batch/Lot Number: EP7534), dose 2 via an unspecified route of administration, administered in left arm on 01Apr2021 (age at the time of vaccination was 41-year-old) as dose 2, single for COVID-19 immunisation. The patient's medical history included previous melanoma, surgical scar on inner left arm. The patient's concomitant medications were not reported. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: solution for injection, Batch/Lot Number: Eh6204), dose 1 via an unspecified route of administration, administered in the left arm on 10Mar2021(age at the time of vaccination was 41-year-old) as dose 1, single for COVID-19 immunisation. It was not reported whether the patient had any other vaccine in 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On an unspecified date in Apr2021, the patient experienced swelling/inflammation of previous melanoma site and surgical scar on inner left arm (vaccination site was also left arm) - no other scars were inflamed during this time. The patient reported that this was the only skin cancer site. The patient described this as very uncomfortable and alarming side effect. On an unspecified date in Apr2021, the patient also experienced swollen lymph nodes on left side of neck. This prompted the patient to seek medical care due to concerns of recurrent cancer. On 08Apr2021, the patient experienced extreme vertigo onset about 7 days after second shot and the vertigo lasted several days and caused patient to miss work and hobbies. The adverse events resulted in doctor/health care professional office/clinic visit. It was reported as unknown for the treatment details of adverse events. The events were considered as non-serious and did not result in death/ Life threatening/Caused/prolonged hospitalization/Disabling/Incapacitating/Congenital anomaly/birth defect. The patient recovered from the events on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
Marked local swelling, erythema, subsequent vesicles per patient with paresthesias down arm. At 1 month follow up; persistent induration of approximately 3 cm.
Diagnosis of double pneumonia one week after vaccines were given. Treated w/ initial antibiotic shots, then oral antibiotic Amoxicillin. This was her 2nd MMR vaccine which was given along w. her first and only Prevnar shot. 5 days after her first MMR which was given w/ a DT@P on 6/23/08, she came down w/ a fever of 101 which lasted for 2 days.  2/6/09 Received clinic & urgent care medical records of 10/8-10/9/2008. FINAL DX: recurring bibasilar pneumonia Urgent care records reveal patient experienced fever, cold s/s, tachpnea & cough x 4 days with increasing breathing difficulty & grunting.  Exam revealed pulse ox 91-92% on RA.  Tx w/IM antibiotic & albuterol.  Seen by PCP next day w/improvement, grunting & fever resolved, decreased appetite.  Tx w/oral antibiotics.  was to return for immunologic w/u & possible pulm clinic referral.
cough x 2 days, fever, fatigue, confusion (transient), AKI, high inflammatory markers
CASE IS SYMPTOMATIC WITH FEVER, COUGH, HEAD ACHE AND RUNNING NOSE, TESTED ON 8/17/202.
I experienced Severe neck pain on the left side and I also experienced forehead twitching for 3 days
Have a red spot near the injection site. That looks like a rash; Rash, sweats, numbness and tingling; Rash, sweats, numbness and tingling; Rash, sweats, numbness and tingling; Rash, sweats, numbness and tingling; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Rash, sweats, numbness and tingling), HYPOAESTHESIA (Rash, sweats, numbness and tingling), PARAESTHESIA (Rash, sweats, numbness and tingling), RASH (Rash, sweats, numbness and tingling) and VACCINATION SITE RASH (Have a red spot near the injection site. That looks like a rash) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 051C21A) for COVID-19 vaccination.     Sojgrens, Lupus, arthritis, small fiber neuropathy.  Concurrent medical conditions included Sjogren's, Lupus syndrome, Arthritis and Small fiber neuropathy.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form once. On 21-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPERHIDROSIS (Rash, sweats, numbness and tingling), HYPOAESTHESIA (Rash, sweats, numbness and tingling), PARAESTHESIA (Rash, sweats, numbness and tingling) and RASH (Rash, sweats, numbness and tingling). On an unknown date, the patient experienced VACCINATION SITE RASH (Have a red spot near the injection site. That looks like a rash). At the time of the report, HYPERHIDROSIS (Rash, sweats, numbness and tingling), HYPOAESTHESIA (Rash, sweats, numbness and tingling), PARAESTHESIA (Rash, sweats, numbness and tingling), RASH (Rash, sweats, numbness and tingling) and VACCINATION SITE RASH (Have a red spot near the injection site. That looks like a rash) had not resolved.            Concomitant products were not reported. No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Follow up received on 25-Jun-2021 contains significant information and an event is added(Have a red spot near the injection site) with unknown date and unknown outcome.
Experienced pain at injection site that NOC. Radiated to back, arm and back sore. Fever and chills initially but subsided. 2 days later was "in agony" seen in ER on 12/24/13. Lyme testing for recent tick bite and urine tested to R/O kidney stone. Ibuprofen, warm pads, Vicodin for pain.
Initial unsolicited report received from a consumer (patient's husband) on 09 November 2015. This case involves a female patient (age not reported) who was vaccinated with a dose of FLUZONE HD (dose, dose in series, route and site of administration were not reported) on 07 November 2015. Medical history and concomitant medications were not reported. On an unknown date, around four hours following the vaccination, the patient had developed a bit of tenderness and a lump about the size of half a baseball at the injection site. The outcomes of events were not reported. List of documents held by sender: none.
This spontaneous report as received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, the patients were vaccinated with the improperly stored doses of VARIVAX (lot # M033905 and expiration date 20-JUL-2018) for prophylaxis. Two of the patients received 0.5 ml of vaccine subcutaneously. There were no adverse effects reported. Administered doses of vaccines experienced defrost cycles and the temperature excursion of 16.4 degrees Fahrenheit for 50 minutes and another temperature excursion greater than 15 degrees Fahrenheit but less than 46 degrees Fahrenheit for 1 hour. Data logger was involved. Additional information has been requested.
20 minutes after the patient was inoculated with Covid Vaccine, the patient experienced severe nausea, lightheadedness. Left-arm was sore at the site of injection immediately after inoculation. To alleviate extreme nausea, that patient contacted her primary care doctor. Doctor immediately prescribed, meclizine to be taken 4x a day. The patient was not able to sleep that night. She was still dizzy and the headache set in. The patient experienced chills and was lethargic. Nausea and headache lingered for 2 1/2 days.
Myalgia, Fever, chills Narrative:  Dec 31 9am fever 100.0 chills body aches
Blood pressure high; puffy at injection site; red at injection site; itchy at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (Blood pressure high), INJECTION SITE SWELLING (puffy at injection site), INJECTION SITE ERYTHEMA (red at injection site) and INJECTION SITE PRURITUS (itchy at injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced HYPERTENSION (Blood pressure high), INJECTION SITE SWELLING (puffy at injection site), INJECTION SITE ERYTHEMA (red at injection site) and INJECTION SITE PRURITUS (itchy at injection site). On 07-Mar-2021, INJECTION SITE SWELLING (puffy at injection site) and INJECTION SITE ERYTHEMA (red at injection site) had resolved. At the time of the report, HYPERTENSION (Blood pressure high) and INJECTION SITE PRURITUS (itchy at injection site) outcome was unknown.            No concomitant product use was reported No treatment information was provided   This case was linked to MOD-2021-041072 (Patient Link).
pt recv vax & devel palsy of the sixth nerve; sx included h/a, confusion, & double vision; reporting MD indicated that the pt was referred by an internist, & dx was based on taking the pts hx & questioning the pt;
Severe swelling to left arm. Pt to see personal MD today 5/2/12. 5/2/12  Personal MD states infected varicella site. Medication given.
Found dead/possible SIDS. Autopsy pending. When found baby was still warm. Tried CPR to no avail. Autopsy report states final anatomic diagnoses: hemorrhges, lungs; s/p ligaton of patent ductus arteriosus; umbilical hernia, small. Death certificate states cause of death to be SIDS.
High Pitched Screaming Fear  Loss of response to sound for a week Fever Tremors
Pt presented in clinic 10/14/06 with clinical disease chicken pox. Had varicella vaccine on 12/21/04.
Symptoms appear approx. 1 day after vaccination.  Presented as a patchy red rash approx.  2 to 3 inches in width around the circumference of upper arm about 2 inches below injection site.  Worsened on the 2nd day, but began to improve on the 3rd day post vaccination.  Patient took fexofenadine to minimize symptoms
pt recv vax 11OCT94 & devel diarrhea x 2 wk;h/a relieved only by light pressure;total body soreness w/arthritic sx from head to toe;felt like skeleton was bruised;
Immun given p/MD exam approx 115pm; @ 455pm mom called ofc indicating pt began vomit 1 hr p/inject; Advised ofc visit; Pt went to ER via ambulance c/o "breathing stopped" p/vomiting; Transported to hosp for admission; D/C 24 hrs;